Clinical Trial Update: Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism [Phase 4]

View source ↗

Summary

This clinical trial update compares safety of low-molecular-weight heparin versus unfractionated heparin when used with thrombolysis for acute massive pulmonary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Ataturk University | Conditions: This Study Will Provide Data Comparing Safety of LMWH Versus UFH in the Treatment of Acute PE Cases Who Require Thrombolytic Treatment. | Phase 4 | Status: UNKNOWN